Lankford Wants To Roll Back Government Price Controls On Prescription Drugs
October 07, 2022
October 07, 2022
OKLAHOMA CITY, Oklahoma, Oct. 7 -- Sen. James Lankford, R-Oklahoma, issued the following news release and letter:
Senator James Lankford (R-OK), a member of the Senate Finance Committee with jurisdiction over the Centers for Medicare and Medicaid Services (CMS), which plays a major role in the prescription drug pricing scheme, joined Senator Mike Lee (R-UT) to introduce the Protecting Drug Innovation Act. The bill would roll back the federal government's authority to set and co . . .
Senator James Lankford (R-OK), a member of the Senate Finance Committee with jurisdiction over the Centers for Medicare and Medicaid Services (CMS), which plays a major role in the prescription drug pricing scheme, joined Senator Mike Lee (R-UT) to introduce the Protecting Drug Innovation Act. The bill would roll back the federal government's authority to set and co . . .